Innovating Works

INSTITUT CATALA D'ONCOLOGIA

Activa
Mostrando 1 al 20 de 36 resultados
DEFINITIVE: Diagnostic HER2DX-guided treatment for patients with early-stage HER2-positive breast cancer FUNDACIO CLINIC PER A LA RECERCA BIOMEDICA tramitó un HORIZON EUROPE: HORIZON-MISS-2023-CANCER-01 HER2+ breast cancer affects around 390.000 women annually worldwide (i.e. 3 patients every 4 minutes). Over the last decade, polychemotherap...
2023-12-11 - 2028-11-30 | Financiado
PIECES: TOWARDS LARGE SCALE ADAPTION AND TAILORED IMPLEMENTATION OF EVIDENCE BASED PRIMARY CANCER PREVENTION... INSTITUT CATALA D'ONCOLOGIA tramitó un HORIZON EUROPE: HORIZON-MISS-2022-CANCER-01 The high and growing global burden of cancer urges the need for effective implementation of primary cancer prevention (PCP) programmes targe...
2023-04-24 - 2027-05-31 | Financiado
PREVENTABLE: CANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLE I3S INSTITUTO DE INVESTIGACAO E INOVACAO EM SAUDE DA UNIVERSIDADE DO PORTO tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-CARE-08 Rare tumour risk syndromes (RTRS) are rare diseases, affecting 5 per 10.000 people or less and caused by heritable genetic variants. In RTRS...
2022-12-02 - 2025-12-31 | Financiado
MELCAYA: Novel health care strategies for melanoma in children adolescents and young adults FUNDACIO CLINIC PER A LA RECERCA BIOMEDICA tramitó un HORIZON EUROPE: HORIZON-MISS-2021-CANCER-02 "In childhood, adolescence and young adults (CAYA), melanoma is under-studied and non-existing tailored clinical guidelines and standardized...
2022-12-01 - 2026-11-30 | Financiado
CGI-Clinics: Data driven cancer genome interpretation for personalised cancer treatment FUNDACIO INSTITUT DE RECERCA BIOMEDICA IRB BARCELONA tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-CARE-05 CGI-Clinics aims at improving personalised medicine in oncology by optimizing genomic data interpretation (after sequencing and before advis...
2022-05-20 - 2027-10-31 | Financiado
RESILIENCE: Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines. CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP tramitó un H2020: H2020-SC1-BHC-2018-2020 The increasing life expectancy of the population and the development of effective therapies result in a growing population of aged cancer su...
2021-01-29 - 2026-05-31 | Financiado
EUREST-RISE: European Regulatory Science on Tobacco Research and Innovation Staff Exchange EUROPEAN NETWORK FOR SMOKING PREVENTION tramitó un H2020: H2020-MSCA-RISE-2020 Smoking and other forms of tobacco consumption are considered the single most important cause of preventable morbidity and premature mortali...
2020-11-20 - 2025-05-31 | Financiado
oncNGS: NGS diagnostics in 21st century oncology the best for all at all times SCIENSANO tramitó un H2020: H2020-SC1-BHC-2018-2020 OncNGS consortium challenges the market to research and develop novel affordable solutions to provide the best NGS tests, for all solid tumo...
2019-12-13 - 2026-04-30 | Financiado
4-IN THE LUNG RUN: 4 IN THE LUNG RUN towards INdividually tailored INvitations screening INtervals and INtegrated co... ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM tramitó un H2020: H2020-SC1-BHC-2018-2020 With 338,000 EU-deaths annually, lung cancer is a devastating problem. CT screening has the potential to prevent ten-thousands of lung cance...
2019-12-06 - 2024-12-31 | Financiado
RISCC: RISK BASED SCREENING FOR CERVICAL CANCER STICHTING AMSTERDAM UMC tramitó un H2020: H2020-SC1-BHC-2018-2020 Screening for cervical cancer is a globally recommended public health policy. Many risk factors are known, but so far only one-size-fits-all...
2019-12-06 - 2024-12-31 | Financiado
HEADSpAcE: Translational studies of HEAD and neck cancer in South America and Europe CNRS UMR 5023 tramitó un H2020: H2020-SC1-BHC-2018-2020 Worldwide, more than 550,000 new cases of head and neck cancer (HNC) occur each year, resulting in approximately 300,000 deaths annually. It...
2018-12-14 - 2024-06-30 | Financiado
EUCANCan: EUCANCan a federated network of aligned and interoperable infrastructures for the homogeneous analy... BARCELONA SUPERCOMPUTING CENTERCENTRO NACIONAL DE SUPERCOMPUTACION tramitó un H2020: H2020-SC1-BHC-2018-2020 We propose to create the EUropean-CANadian Cancer network (EUCANCan), a federated infrastructure whose mission is to enable Personalized Med...
2018-12-04 - 2023-06-30 | Financiado
EDIReX: EurOPDX Distributed Infrastructure for Research on patient derived cancer Xenografts UNIVERSITA DEGLI STUDI DI TORINO tramitó un H2020: H2020-INFRAIA-2016-2017 Counteracting high attrition rates in oncology drug development and providing optimal therapeutic management of cancer patients require prec...
2017-12-08 - 2022-07-31 | Financiado
MEDIRAD: Implications of Medical Low Dose Radiation Exposure EIBIR GEMEINNUTZIGE GMBH ZUR FORDERUNG DER ERFORSCHUNG DER BIOMEDIZINISCHEN BILDGEBUNG tramitó un H2020: NFRP-2016-2017 MEDIRAD aims to enhance the scientific bases and clinical practice of radiation protection (RP) in the medical field and thereby addresses t...
2017-05-26 - 2022-02-28 | Financiado
ANTI-SUPERBUGS PCP: ANTI SUPERBUGS Precommercial procurement AGENCIA DE QUALITAT I AVALUACIO SANITARIES DE CATALUNYA tramitó un H2020: H2020-ICT-2015 Infections caused by resistant microorganisms often fail to respond to the standard treatment, resulting in prolonged hospital stays, higher...
2016-08-05 - 2022-02-28 | Financiado
AngioResist: Coordinated Development of Inhibitors and Biomarkers for Resistance to Antiangiogenics in Cancer A... INSTITUT CATALA D'ONCOLOGIA tramitó un H2020: ERC-2015-PoC Many anti-angiogenic drugs are clinically used in several types of cancer to block angiogenesis, impair tumor growth, progression and dissem...
2016-08-04 - 2018-02-28 | Financiado
EUREST-PLUS: European Regulatory Science on Tobacco Policy implementation to reduce lung diseases EUROPEAN NETWORK FOR SMOKING PREVENTION tramitó un H2020: H2020-HCO-2014-2015 Smoking and other forms of tobacco consumption are considered the single most important cause of preventable morbidity and premature mortali...
2016-04-06 - 2018-12-31 | Financiado
TackSHS: Tackling secondhand tobacco smoke and e cigarette emissions exposure assessment novel intervention... INSTITUT CATALA D'ONCOLOGIA tramitó un H2020: H2020-HCO-2014-2015 "Exposure to secondhand tobacco smoke (SHS) has been classified as a ""Group 1 carcinogen (known human carcinogen) by the International Age...
2015-09-11 - 2019-10-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.